Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)

• Register: ANZCTR
• Last refreshed on: 13 January 2020
• Main ID: ACTRN12611001255976
• Date of registration: 07/12/2011
• Prospective Registration: Yes
• Primary sponsor: Clifford Craig Medical Trust Fund
• Public title: Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)
• Scientific title: Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)
• Date of first enrolment: 01/01/2012
• Target sample size: 1200
• Recruitment status: Completed
• URL: https://anzctr.org.au/ACTRN12611001255976.aspx
• Study type: Observational
• Study design: Purpose: Natural history;Duration: Longitudinal;Selection: Defined population;Timing: Prospective;
• Phase: Not Applicable

Countries of recruitment

Australia

Contacts

• Name: Prof A/Professor Alhossain A. Khalafallah

• Name: Prof A/Professor Alhossain A. Khalafallah

Key inclusion & exclusion criteria

Inclusion criteria: Medical patients with documented VTE from both sexes
Exclusion criteria: None

Age minimum: No limit
Age maximum: No limit
Gender: Both males and females

Health Condition(s) or Problem(s) studied

Venous thromboembolism (VTE) among medical patients.;
Venous thromboembolism (VTE) among medical patients.

Blood - Clotting disorders

Intervention(s)

To assess the prevalence of venous thromboembolism (VTE) among medical patients.
Via assessment of all ulterasound or scans performed at the LGH for medical patients. The observation time is 6 months.

Primary Outcome(s)

Venous thromboembolism (VTE).
Assessed by ultrasound or VQ-scan or CT-pulmonary angiogram[This timepoint will be assessed continously until the end of the study.]

Secondary Outcome(s)

Assess risk factors of VTE
Via correlation with the international criteria of VTE-risk with clinical assessments as well as radiological findings and labortaory tests.[This timepoint will be assessed continously until the end of the study.]

Secondary ID(s)

None

Source(s) of Monetary Support

Launceston General Hospital

Ethics review

Status: Approved
Approval date:
Contact:

Tasmanian Human Research Ethics Committee